Press Release Archive
BPGbio, Inc. acquired substantially all of the assets of Berg, LLC, and licenses from Berg, LLC the use of the Berg and Berg Health names.
-
November 30, 2021 |
Media, Press Releases
AFFPC Celebrates Giving Tuesday By Donating $200,000.00 To BERG’s Project Survival
read moreFunds will support AFFPC’s vision to transform pancreatic cancer treatment through frontline research News provided by BERG Health Nov 30, 2021, 09:00 ET PALM BEACH GARDENS, Fla., Nov. 30, 2021 The Alliance of Families Fighting Pancreatic Cancer (AFFPC) today announced the donation of $200,000.00 to BERG, the clinical stage biotech that employs patient biology and artificial intelligence…
-
November 8, 2021 |
Media, Press Releases
BERG Presents New Research on Potential Therapeutic Path to Fight Huntington’s Disease at The Society for Neuroscience (SfN) Annual Meeting
read moreResults Will Unveil Advancements Aimed to Help Fight this Deadly Disease News provided by BERG Health Nov 08, 2021, 09:00 ET FRAMINGHAM, Mass., Nov. 8, 2021 /PRNewswire/ — BERG, the clinical stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today announced their participation at…
-
September 16, 2021 |
Media, Press Releases
BERG to Present Latest Research to Improve Pancreatic Treatment at The European Society for Medical Oncology (ESMO) 2021 Congress
read moreResearch will unveil cutting-edge technology to improve the lives of patients suffering from this deadly disease News provided by BERG Health Sep 16, 2021, 09:01 ET FRAMINGHAM, Mass., Sept. 16, 2021 /PRNewswire/ — BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today…
-
July 29, 2021 |
Media, Press Releases
BERG Reveals New Study That Will Seek to Enhance Diagnosis and Treatment of Prostate Cancer
read moreDevelops First AI Blood-Based Biomarker for Disease Diagnosis News provided by BERG Health Jul 29, 2021, 09:30 ET FRAMINGHAM, Mass., July 29, 2021 /PRNewswire/ — BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments and diagnostics, today announced the publication of a new study,…
-
July 14, 2021 |
Media, Press Releases
BERG To Present Latest Glioblastoma [GBM] Treatment Data At Society For Neuro-Onocology 2021 Meeting
read moreBERG’s presentations will explore mechanics of BERG’s Interrogative Biology® Platform and application of BPM 31510’s anti-cancer influence on GBM News provided by BERG Health Jul 14, 2021, 09:30 ET FRAMINGHAM, Mass., July 14, 2021 /PRNewswire/ — BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop…
-
June 2, 2021 |
Media, Press Releases
BERG to Present Phase 1 Results of BPM 31510-IV and Identifies Therapeutic Opportunities for Recurrent GBM Patients at 2021 American Society of Clinical Oncology (ASCO) Meeting
read moreResults Will Advance Understanding of Potential Predictive Responses of Markers in High-Grade Brain Cancer Patients News provided by BERG Health Jun 02, 2021, 08:30 ET FRAMINGHAM, Mass., June 2, 2021 /PRNewswire/ — BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today announced results from…